Surepharm Midco Limited
Company profile
DissolvedUnited Kingdom
Financial position
Accounts to 2023-10-31 · GBP · unknown scope
Net assets
−£1,650,592
Cash
—
Turnover
£0
Profit / loss
−£1,091,399
Current assets
—
Creditors < 1 year
—
Equity
−£1,650,592
Average employees
0
Balance-sheet trend
GBP · unknownTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2023-10-31GBP · unknown | 2022-10-31GBP · unknown |
|---|---|---|
| Balance sheet | ||
| Net assets | −£1,650,592 | −£559,193 |
| Equity | −£1,650,592 | −£559,193 |
| Assets | ||
| Debtors | £9,430,089 | £8,930,089 |
| Liabilities | ||
| Net current assets | £8,920,731 | £8,420,731 |
| Assets less current liabilities | £8,920,732 | £8,420,732 |
| Profit & loss | ||
| Turnover | £0 | £0 |
| Operating profit | £0 | £0 |
| Profit before tax | −£1,091,399 | −£559,194 |
| Profit / loss | −£1,091,399 | −£559,194 |
| People | ||
| Average employees | 0 | 0 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
5 outstanding chargesRegister status requires review: Dissolved.
All Assets · created 2024-10-11
—
OutstandingAll Assets · created 2024-05-23
—
OutstandingAll Assets · created 2024-04-24
—
OutstandingAll Assets · created 2023-09-28
—
OutstandingAll Assets · created 2022-01-26
—
OutstandingShow 1 satisfied / released
Floating · created 2022-01-26 · satisfied 2025-01-23
—
Satisfied